000 | 01968 a2200529 4500 | ||
---|---|---|---|
005 | 20250517160640.0 | ||
264 | 0 | _c20180402 | |
008 | 201804s 0 0 eng d | ||
022 | _a1873-281X | ||
024 | 7 |
_a10.1016/j.tube.2017.05.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Knegt, Gerjo J | |
245 | 0 | 0 |
_aAssessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model. _h[electronic resource] |
260 |
_bTuberculosis (Edinburgh, Scotland) _c07 2017 |
||
300 |
_a113-118 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
650 | 0 | 4 |
_aBacterial Load _xdrug effects |
650 | 0 | 4 | _aColony Count, Microbial |
650 | 0 | 4 |
_aDNA, Bacterial _xgenetics |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEthambutol _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aIsoniazid _xpharmacology |
650 | 0 | 4 |
_aLung _xdrug effects |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 | _aNonlinear Dynamics |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 |
_aPyrazinamide _xpharmacology |
650 | 0 | 4 |
_aRNA, Ribosomal, 16S _xgenetics |
650 | 0 | 4 | _aRibotyping |
650 | 0 | 4 |
_aRifampin _xpharmacology |
650 | 0 | 4 |
_aStreptomycin _xpharmacology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdiagnosis |
700 | 1 | _aDickinson, Laura | |
700 | 1 | _aPertinez, Henry | |
700 | 1 | _aEvangelopoulos, Dimitrios | |
700 | 1 | _aMcHugh, Timothy D | |
700 | 1 | _aBakker-Woudenberg, Irma A J M | |
700 | 1 | _aDavies, Gerry R | |
700 | 1 | _ade Steenwinkel, Jurriaan E M | |
773 | 0 |
_tTuberculosis (Edinburgh, Scotland) _gvol. 105 _gp. 113-118 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tube.2017.05.002 _zAvailable from publisher's website |
999 |
_c27274163 _d27274163 |